Search results
CymaBay Therapeutics Inc. (CBAY) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 2 years agoAfter reaching an important support level, CymaBay Therapeutics Inc. (CBAY) could be a good stock...
Does CymaBay Therapeutics Inc. (CBAY) Have the Potential to Rally 45.99% as Wall Street Analysts...
Zacks via Yahoo Finance· 6 months agoThe average of price targets set by Wall Street analysts indicates a potential upside of 46% in...
Why CymaBay Morphed From Dollar Stock To Biotech Rocket
Investor's Business Daily· 4 months agoCymaBay Therapeutics is sprinting to the finish line with a breakthrough treatment for a serious...
CymaBay Therapeutics Inc. (CBAY) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks via Yahoo Finance· 11 months agoCymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a...
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 8 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...
Institutional investors own a significant stake of 50% in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)
Simply Wall St. via Yahoo Finance· 2 years agoTo get a sense of who is truly in control of CymaBay Therapeutics, Inc. (NASDAQ:CBAY), it is...
How Many CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Shares Do Institutions Own?
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls CymaBay Therapeutics, Inc. (NASDAQ:CBAY), then you'll have...
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) may have lost US$34m in value but insiders who invested...
Simply Wall St. via Yahoo Finance· 1 year agoInsiders who bought CymaBay Therapeutics, Inc. (NASDAQ:CBAY) stock lover the last 12 months are...
Trade Alert: The President Of CymaBay Therapeutics, Inc. (NASDAQ:CBAY), Sujal Shah, Has Just Spent...
Simply Wall St. via Yahoo Finance· 2 years agoPotential CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shareholders may wish to note that the President,...
Industry Analysts Just Upgraded Their CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Revenue Forecasts By...
Simply Wall St. via Yahoo Finance· 4 months agoCelebrations may be in order for CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shareholders, with the...